1-3 of 3
Melissa Parker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Axatilimab Abrogates Inflammatory Cytokines and Chemokines and Interrupts the Differentiation of Monocytes to Macrophages, a Pathogenic Driver of Inflammation and Fibrosis in Cghvd

Anamika Bajpai, Linda Solomon, Angelina Volkova, Melissa Parker, James Kearns, Shekinah Cosby, Chryssa Kanellopoulou
Journal: Blood
Blood (2024) 144 (Supplement 1): 1147.
https://doi.org/10.1182/blood-2024-207658
Published: 2024
Journal Articles

Prophylactic Itacitinib (INCB039110) for the Prevention of Cytokine Release Syndrome Induced By Chimeric Antigen Receptor T-Cells (CAR-T-cells) Therapy

Eduardo Huarte, PhD, Roddy S O'Connor, PhD, Melissa Parker, Taisheng Huang, Michael C. Milone, Paul Smith
Journal: Blood
Blood (2019) 134 (Supplement_1): 1934.
https://doi.org/10.1182/blood-2019-128288
Published: 2019
Journal Articles

Ruxolitinib, a JAK1/JAK2 Selective Inhibitor, Ameliorates Gastrointestinal and Cutaneous Pathogenesis in MHC-Mismatched Preclinical Models of Acute and Chronic Graft-Versus-Host Disease

Eduardo Huarte, PhD, Melissa Parker, Ashish Juvekar, Julian Oliver, Wenqing Yao, Paul Smith
Journal: Blood
Blood (2019) 134 (Supplement_1): 5608.
https://doi.org/10.1182/blood-2019-126749
Published: 2019